Manage hypertension effectively by combining evidence-based natural strategies like the DASH diet, CoQ10, and hibiscus tea with prescribed medications. Learn what works, what doesn’t, and how to do it safely.
Learn the essential questions to ask your pharmacist about medication interactions to avoid dangerous side effects. Get practical advice on drug, food, and supplement interactions based on current safety guidelines.
Learn how to protect your health data when using online pharmacies in 2026. Discover the signs of legitimate sites, why most are unsafe, and the 5-step plan to avoid data theft and counterfeit drugs.
Generic combination drugs save money but may contain different inactive ingredients than brand names, causing side effects or reduced effectiveness in sensitive patients. Learn who’s at risk and what to do.
Huntington’s disease is a genetic, progressive brain disorder causing chorea, cognitive decline, and emotional changes. Learn how genetics drive the disease, why chorea happens, and how early care planning can extend life and improve quality.
Learn how to successfully appeal a prior authorization denial for your medication. Discover the steps, documentation, and strategies that lead to an 82% approval rate when done correctly.
Learn which cough and allergy medications are safe during breastfeeding and which ones pose serious sedation risks to infants. Get clear guidance on safe alternatives, timing tips, and what to watch for in your baby.
Antibiotics can cause dangerous INR spikes in people taking warfarin, increasing bleeding risk. Learn which antibiotics are most risky, when to monitor INR, and how to prevent life-threatening complications.
Opioids aren't safer or more effective for chronic pain than non-opioid options - and they carry serious risks. Learn why experts now recommend NSAIDs, acetaminophen, and newer drugs like Journavx as first-line treatments.
Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and is paid at 100% of its ASP plus 6% of the reference product’s price. This structure affects provider incentives and patient access.
